Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 Diabetes

Novo Nordisk

Status: Completed

Conditions: Diabetes Mellitus, Type 1; Diabetes; Diabetes Mellitus, Type 2

Treatments: Drug: insulin detemir

Study type: Observational

Funder types: Industry

Identifiers

NCT00700765

NN304-3528

Details and patient eligibility

About

This study is conducted in Asia. The aim of this observational study is to evaluate the incidence of adverse events while using Levemir® under normal clinical practice conditions.

Enrollment: 1,531 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Type 1 or type 2 diabetes mellitus

Exclusion criteria

• Subjects who are unlikely to comply with the protocol
• Subjects who are currently being treated with Levemir®
• Subjects who previously were enrolled into the study
• Subjects with hypersensitivity to Levemir® or any of its excipients

Trial design

1,531 participants in 1 patient group

A

Treatment:

Drug: insulin detemir